CMS NCD 341 Update: Ornish Program for Reversing Heart Disease Coverage Policy (2026)

CMS has issued a modification to National Coverage Determination (NCD) 341, which governs Medicare coverage of the Ornish Program for Reversing Heart Disease under the Intensive Cardiac Rehabilitation (ICR) benefit category. While the foundational coverage criteria remain anchored to the August 12, 2010 effective date, this 2026 review signals renewed CMS attention to ICR program compliance—and billing teams at cardiac rehab facilities need to confirm their program approval status before submitting claims.

What Is CMS NCD 341 and What Does It Cover?

The Centers for Medicare & Medicaid Services (CMS) NCD 341 establishes Medicare's national coverage policy for the Ornish Program for Reversing Heart Disease—also known as the Multisite Cardiac Lifestyle Intervention Program, the Multicenter Cardiac Lifestyle Intervention Program, and the Lifestyle Heart Trial Program. This distinction in naming matters for billing teams because claims may reference the program under any of these aliases, and all fall under the same NCD.

The Ornish Program was initially described in the 1970s and has been refined over decades. Its core components remain consistent: structured exercise, a low-fat diet, smoking cessation, stress management training, and group support sessions. These aren't optional lifestyle recommendations—they are the defining clinical elements that qualify the program as an Intensive Cardiac Rehabilitation program under Medicare.

CMS first extended Medicare coverage to the Ornish Program effective August 12, 2010, recognizing it as meeting the ICR program requirements set forth in §1861(eee)(4)(A) of the Social Security Act and regulations at 42 C.F.R. §410.49(c). That statutory and regulatory framework is the foundation for all ICR billing under this NCD, and it hasn't changed with this 2026 modification.

CMS ICR Coverage Criteria Under NCD 341

Medicare coverage under NCD 341 hinges on a single, non-negotiable requirement: the program must appear on CMS's list of approved Intensive Cardiac Rehabilitation programs. Coverage is not determined by the clinical components alone—it is contingent on institutional approval status.

Nationally Covered Indications apply when:

Nationally Non-Covered Indications apply when:

This is a clean binary: approved and listed = covered; not listed = non-covered. There is no gray area, no case-by-case medical necessity exception, and no prior authorization process described in this NCD that can override non-approval status.

For billing managers, this means denial risk isn't primarily about diagnosis or documentation—it's about facility approval status. An otherwise perfect claim will be denied if the facility isn't on that CMS list.

Affected Codes

This policy does not list specific CPT or HCPCS codes in its current published form. Billing teams should reference the CMS Claims Processing Transmittal TN 12497 (Medicare Claims Processing) for applicable procedure codes used to bill ICR services under this NCD. ICR services are generally billed under the broader cardiac rehabilitation benefit, and code selection should align with the approved program structure and session documentation requirements.

Related ICD-10 Diagnosis Codes

This NCD does not enumerate specific ICD-10-CM diagnosis codes. Coverage is determined by program approval status, not by a list of covered diagnoses. However, ICR claims are typically associated with diagnoses tied to coronary artery disease, acute myocardial infarction, coronary artery bypass surgery, stable angina, heart valve repair or replacement, or coronary stenting—conditions that align with the broader Medicare ICR benefit. Billing teams should ensure diagnosis coding reflects the underlying cardiac condition driving ICR enrollment, consistent with standard ICR coverage criteria at 42 C.F.R. §410.49.

Why This 2026 Modification Matters for Revenue Cycle Teams

CMS modifications to NCDs—even those that don't overhaul coverage criteria—carry operational weight. A modified NCD signals that CMS has reviewed the policy, and that review may precede more substantive changes in future revisions. For cardiac rehab programs operating under NCD 341, this is the right moment to audit your compliance posture.

There are three scenarios where this policy creates billing risk:

1. Your facility was approved but you haven't verified current list status. CMS's approved ICR program list can change, and facilities have lost approved status for various administrative and compliance reasons. Do not assume continued approval—verify it.

2. Your facility is offering the Ornish Program components without formal ICR program approval. Delivering the clinical content of the Ornish Program without appearing on the CMS approved list means every ICR claim you submit is nationally non-covered under this NCD.

3. Your billing team is unfamiliar with the program name variants. Claims documentation referencing the Multisite Cardiac Lifestyle Intervention Program or Lifestyle Heart Trial Program are all subject to NCD 341. Ensure your coders recognize all four program names as falling under the same policy.

What Your Billing Team Should Do